Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: opalapril who wrote (12318)	11/23/1999 2:11:00 PM
From: aknahow	Read Replies (1) \| Respond to of 17367

Have just registered Placebo.com. Money losing Bloomberg web site does not call Cellergy a money losing biotech. Think they reserve that term for just special occasions. The drug did better than the placebo only in reducing pain. While the Bloomberg reporter did not mention the reason for this it is thought by some, R.K., in fact might be among them, that swabbing nitroglycerine on a fissure you sit on might make you sit down with great care. P IV trials have been suggested to determine if different sitting habits accounted for the reduction in pain. Many in the treatment group did report what they claimed were small explosions, when they sat down quickly after a heavy meal. Since the dread Placebo did better than BPI in the XOMA, Trauma trial I think we are on to something here. Am worried about having to run any clinical trials with the FDA should I actually try to get Placebo approved. Although it often seems to perform as well as the drugs it is tested against, the problem is what can I use to test my Placebo against? Sorry, too late. Placebo is taken. Strange site. Go there.